Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Conference Abstracts
, 2016, 'Australian cladribine experience', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 289 - 290, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016
, 2016, 'Comparison of 5-year treatment outcomes between alemtuzumab versus natalizumab, fingolimod and interferon β-1a', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 829 - 832, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016
, 2016, 'Individual response to disease modifying therapies: a global observational cohort study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 358 - 360, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016
, 2016, 'MSFIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 342 - 343, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016
, 2016, 'Pregnancy protects against long-term disability accrual in relapsing-remitting MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 120 - 122, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016
, 2016, 'Activation of Human CD4+CD25+CD127loFOXP3+Treg by IL-4 and alloantigen induces activated Treg that do not express CD45RA and express the IL-5 receptor alpha (CD125)', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S460 - S460, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953201100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Recently alloactivated CD4+CD8-CD25+Treg express CD8 and are the antigen-specific Treg', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S120 - S120, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'In Vitro Reactivity of CD4(+) T Cells Subsets from Hosts with Antigen Specific Transplant Tolerance Mediated by CD4(+)CD25(+) T Cells', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, MA, Boston, Vol. 16, pp. 512 - 512, presented at American Transplant Congress, MA, Boston, 11 June 2016 - 15 June 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383373903337&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Interleukin-5 therapy prevents chronic allograft rejection by induction of antigen specific CD4+CD25+T regulatory cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S65 - S65
, 2015, 'Efficacy and Safety of Natalizumab in Multiple Sclerosis: Interim Observational Program Results from an Australian Cohort.', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SOUTH KOREA, Seoul, Vol. 22, pp. 419 - 420, presented at 8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS), SOUTH KOREA, Seoul, 19 November 2015 - 21 November 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000372242400088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'Interleukin-5 therapy prevents chronic allograft rejection by introduction of T regulatory cells.', in Transplantation, Lippincott, Williams & Wilkins, Lorne, AUSTRALIA, Vol. 99, pp. S4 - S4, presented at 14th Transplantation Science Symposium of the Transplantation-Society (TSS), Lorne, AUSTRALIA, 11 November 2015 - 13 November 2015
, 2015, 'Recently alloactivated CD4+CD8-CD25+TREG express CD8 and are the antigen-specific TREG', in Transplantation, Lippincott, Williams & Wilkins, Lorne, AUSTRALIA, Vol. 99, pp. S34 - S34, presented at 14th Transplantation Science Symposium of the Transplantation-Society (TSS), Lorne, AUSTRALIA, 11 November 2015 - 13 November 2015
, 2015, 'First-line injectable therapy and pregnancy protect against long-term disability accrual in patients with relapse-onset multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, Vol. 21, pp. NP15 - NP15, presented at MS Research Australia Progress in MS Research Conference, AUSTRALIA, Melbourne, 29 October 2015 - 30 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365611900037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, Vol. 21, pp. NP14 - NP14, presented at MS Research Australia Progress in MS Research Conference, AUSTRALIA, Melbourne, 29 October 2015 - 30 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365611900036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, '10-year progression predictors after first treatment initiation in a relapsing-remitting MS cohort', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 100 - 102, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729400172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'Effect of relapse phenotype on the accumulation of disability in relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 726 - 728, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729402256&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 308 - 310, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729401014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'Interleukin 5 mediates disease protection associated with parasite infestation in EAE', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 430 - 430, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015
, 2015, 'MS FIRST - utilising a drug safety module for use in MS clinical practice to evaluate lymphocyte reduction in fingolimod treatment over time, demographic predictors of lymphopenia and association with reported safety events', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 18 - 19, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729400025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'Natural CD4(+)CD25(+)T regulatory cells (nTreg) cultured with antigen and Th2 cytokines, suppress induction of EAE', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 537 - 537, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729401427&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'Risk of early relapse following switch to oral agents for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, Vol. 21, pp. 270 - 271, presented at 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 07 October 2015 - 10 October 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365729400466&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'A novel small molecule neurotrophin-based strategy for treating demyelinating diseases', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, AUSTRALIA, Cairns, Vol. 134, pp. 285 - 285, presented at 25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society, AUSTRALIA, Cairns, 23 August 2015 - 27 August 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360206300717&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'INDUCTION OF POTENT ANTIGEN SPECIFIC TREG CELLS FROM NAIVE TTREG BY ALLOANTIGEN AND TH2 CYTOKINES', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, Vol. 93, pp. A31 - A31, presented at 33rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New Zealand, AUSTRALIA, ANU Campus, Canberra, 21 June 2015 - 23 June 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363320100078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'INTERLEUKIN-5 THERAPY PREVENTS CHRONIC ALLOGRAFT REJECTION BY INDUCTION OF T REGULATORY CELLS', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, Vol. 93, pp. A31 - A31, presented at 33rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New Zealand, AUSTRALIA, ANU Campus, Canberra, 21 June 2015 - 23 June 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363320100077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'RECENTLY ALLOACTIVATED CD4+CD8-CD25+TREG EXPRESS CD8 AND ARE THE ANTIGEN SPECIFIC TREG', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, Vol. 93, pp. A29 - A29, presented at 33rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New Zealand, AUSTRALIA, ANU Campus, Canberra, 21 June 2015 - 23 June 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363320100073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Evaluation of common criteria of progression of disability in a large observational cohort', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MA, Boston, Vol. 20, pp. 62 - 63, presented at Joint ACTRIMS-ECTRIMS Meeting, MA, Boston, 10 September 2014 - 13 September 2014
, 2014, 'Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MA, Boston, Vol. 20, pp. 195 - 196, presented at Joint ACTRIMS-ECTRIMS Meeting, MA, Boston, 10 September 2014 - 13 September 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354441300452&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MA, Boston, Vol. 20, pp. 193 - 193, presented at Joint ACTRIMS-ECTRIMS Meeting, MA, Boston, 10 September 2014 - 13 September 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354441300448&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Interleukin-12 Promotes Induction of Potent Th1-Like CD4(+)CD25(+)T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Hosts.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CA, San Francisco, Vol. 98, pp. 24 - 24, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014, http://dx.doi.org/10.1097/00007890-201407151-00070
, 2014, 'Interleukin-5 Therapy Prevents Chronic Allograft Rejection By Induction of T Regulatory Cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CA, San Francisco, Vol. 98, pp. 403 - 403, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014, http://dx.doi.org/10.1097/00007890-201407151-01329
, 2014, 'The Test for Tolerance - Diagnosing Transplant Tolerance By In Vitro Assay of CD4(+)CD25(+)T Cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CA, San Francisco, Vol. 98, pp. 401 - 401, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014, http://dx.doi.org/10.1097/00007890-201407151-01323
, 2014, 'Interleukin-5 Therapy Prevents Chronic Allograft Rejection By Induction of T Regulatory Cells', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, CA, San Francisco, Vol. 14, pp. 403 - 403, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000338033301678&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'The Test for Tolerance - Diagnosing Transplant Tolerance By In Vitro Assay of CD4(+)CD25(+)T Cells', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, CA, San Francisco, Vol. 14, pp. 401 - 401, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000338033301672&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'INTERLEUKIN-12 PROMOTES INDUCTION OF POTENT TH1-LIKE CD4(+)CD25(+)T REGULATORY CELLS THAT INHIBIT ALLOGRAFT REJECTION IN UNMODIFIED HOSTS', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, Vol. 92, pp. A24 - A24, presented at 32nd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, AUSTRALIA, ANU Campus, Canberra, 10 June 2014 - 13 June 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342376300058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Interleukin-5 Therapy Prevents Chronic Allograft Rejection By Induction of T Regulatory Cells', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, ANU Campus, Canberra, AUSTRALIA, Vol. 92, pp. A25 - A25, presented at 32nd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, ANU Campus, Canberra, AUSTRALIA, 10 June 2014 - 13 June 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342376300061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'THE TEST FOR TOLERANCE: TEST OF TRANSPLANT TOLERANCE BY IN VITRO ASSAY OF CD4(+)CD25(+)T CELLS', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, Vol. 92, pp. A23 - A23, presented at 32nd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, AUSTRALIA, ANU Campus, Canberra, 10 June 2014 - 13 June 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342376300056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'A BDNF MIMETIC PROMOTES PERIPHERAL MYELIN DEVELOPMENT AND AMELIORATES EXPERIMENTAL AUTOIMMUNE NEURITIS (EAN)', in GLIA, WILEY-BLACKWELL, GERMANY, Berlin, Vol. 61, pp. S85 - S85, presented at 11th European Meeting on Glial Cell Function in Health and Disease, GERMANY, Berlin, 03 July 2013 - 06 July 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000320408400263&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'SIGNIFICANT PROTECTION BY EPCR OVEREXPRESSION IN MOUSE MODELS OF TRANSPLANTATION', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 17, pp. 75 - 75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400186&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2011, 'Protective effects of EPCR overexpression in mouse cardiac xenografts and islet isografts', in XENOTRANSPLANTATION, WILEY-BLACKWELL, FL, Miami, Vol. 18, pp. 295 - 295, presented at Joint International Congress of the Cell-Transplant-Society(CTS)/International-Xenotransplantation-Association (IXA), FL, Miami, 23 October 2011 - 26 October 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295092900092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2011, 'OVEREXPRESSING ENDOTHELIAL PROTEIN C RECEPTOR PROTECTS AGAINST INFLAMMATION AND THROMBOSIS IN MODELS OF ORGAN TRANSPLANTATION', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 16, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294977600002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2009, 'INTERLEUKIN 5 (IL-5) PREVENTS AUTOIMMUNE MEDIATED DEMYELINATION BY ACTIVATION OF ANTIGEN SPECIFIC CD4+CD25+T REGULATORY CELLS', in Journal of the Peripheral Nervous System, Woodland Publications, New York, NY, USA, pp. 65 - 65
, 2009, 'MEMBRANE ATTACK COMPLEX OF COMPLEMENT IS NOT ESSENTIAL FOR IMMUNE MEDIATED DEMYELINATION BUT IS ASSOCIATED WITH REDUCED TH17', in Journal of the Peripheral Nervous System, Woodland Publications, New York, NY, USA, pp. 145 - 145
, 2007, 'ABSENCE OF MEMBRANE ATTACK COMPLEX (MAC), DELAYS ONSET OF PROTEINURIA IN HEYMANN NEPHRITIS (HN)', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 12, pp. A12 - A12, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2007, 'ALLOGRAFT TOLERANCE MEDIATING CD4+T CELLS DEPEND UPON INTERFERON-GAMMA (IFN-gamma) OR INTERLEUKIN-5 (IL-5)', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 12, pp. A17 - A17, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2007, 'TH1 AND TH2 RESPONSES INDUCE SEPARATE LINEAGES OF CD4+CD25+T CELLS THAT MEDIATE ALLOGRAFT TOLERANCE', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 12, pp. A14 - A14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2007, '633: Therapy with interleukin 5 suppresses autoimmune T cell mediated peripheral nerve demyelination in EAN and increases CD4+CD25+cells', in Journal of Clinical Neuroscience, Elsevier BV, Vol. 14, pp. 1029 - 1029, http://dx.doi.org/10.1016/j.jocn.2007.02.064
, 2007, '647: CD4+CD25+ T cells prevent induction of demyelination in experimental allergic neuritis (EAN)', in Journal of Clinical Neuroscience, Elsevier BV, Vol. 14, pp. 1034 - 1035, http://dx.doi.org/10.1016/j.jocn.2007.02.078
, 2006, 'The role of membrane attack complex (MAC) in complement component C6 deficient Lewis rat', in JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE BV, JAPAN, Nagoya, Vol. 178, pp. 58 - 58, presented at 8th International Conference of Neuroimmunology, JAPAN, Nagoya, 15 October 2006 - 19 October 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241633100140&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'Antigen-specific CD4+CD25+ T cells prevent induction of demyelination in experimental allergic neuritis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Madrid, Vol. 12, pp. S50 - S50, presented at 22nd Congress of the European-Committee-for-the-Treatment-and-Research-in-Multiple-Sclerosis, SPAIN, Madrid, 27 September 2006 - 30 September 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241921400162&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'Membrane attack complex is not required for demyelination in experimental allergic neuritis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Madrid, Vol. 12, pp. S50 - S50, presented at 22nd Congress of the European-Committee-for-the-Treatment-and-Research-in-Multiple-Sclerosis, SPAIN, Madrid, 27 September 2006 - 30 September 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241921400163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1